|
1
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer Statistics, 2001. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cognetti DM, Weber RS and Lai SY: Head and
neck cancer: An evolving treatment paradigm. Cancer. 113:(7 Suppl).
S1911–S1932. 2008. View Article : Google Scholar
|
|
3
|
Inglehart RC, Scanlon CS and D'Silva NJ:
Reviewing and reconsidering invasion assays in head and neck
cancer. Oral Oncol. 50:1137–1143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kiyota N, Tahara M and Fujii M: Adjuvant
treatment for post-operative head and neck squamous cell carcinoma.
Jpn J Clin Oncol. 45:2–6. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P
and Lesniak MS: Chemokines in tumor progression and metastasis.
Oncotarget. 4:2171–2185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruffini PA, Morandi P, Cabioglu N,
Altundag K and Cristofanilli M: Manipulating the
chemokine-chemokine receptor network to treat cancer. Cancer.
109:2392–2404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Xi L, Hunt JL, Gooding W,
Whiteside TL, Chen Z, Godfrey TE and Ferris RL: Expression pattern
of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma
of the head and neck identifies a novel metastatic phenotype.
Cancer Res. 64:1861–1866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J, Seethala RR, Zhang Q, Gooding W,
van Waes C, Hasegawa H and Ferris RL: Autocrine and paracrine
chemokine receptor 7 activation in head and neck cancer:
Implications for therapy. J Natl Cancer Inst. 100:502–512. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Babon JJ, Lucet IS, Murphy JM, Nicola NA
and Varghese LN: The molecular regulation of Janus kinase (JAK)
activation. Biochem J. 462:1–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rivas-Caicedo A, Soldevila G, Fortoul TI,
Castell-Rodríguez A, Flores-Romo L and García-Zepeda EA: Jak3 is
involved in dendritic cell maturation and CCR7-dependent migration.
PLoS One. 4:e70662009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
García-Zepeda EA, Licona-Limón I,
Jiménez-Sólomon MF and Soldevila G: Janus kinase 3-deficient T
lymphocytes have an intrinsic defect in CCR7-mediated homing to
peripheral lymphoid organs. Immunology. 122:247–260. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loh KC, Greenspan FS, Gee L, Miller TR and
Yeo PP: Pathological tumor-node-metastasis (pTNM) staging for
papillary and follicular thyroid carcinomas: A retrospective
analysis of 700 patients. J Clin Endocrinol Metab. 82:3553–3562.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through MAPKs in metastatic squamous cell carcinoma of head and
neck. Int J Oncol. 45:2502–2510. 2014.PubMed/NCBI
|
|
14
|
Winquist E, Al-Rasheedy I, Nichols AC,
Palma DA and Stitt L: Temporal changes in the efficacy of
chemotherapy for recurrent or metastatic squamous cell carcinoma of
the head and neck: A systematic review and meta-analysis. Cancer
Treat Rev. 40:1073–1079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nelke KH, Pawlak W, Gerber H and
Leszczyszyn J: Head and Neck Cancer Patients' Quality of Life. Adv
Clin Exp Med. 23:1019–1027. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noorlag R, van Kempen PM, Stegeman I,
Koole R, van Es RJ and Willems SM: The diagnostic value of 11q13
amplification and protein expression in the detection of nodal
metastasis from oral squamous cell carcinoma: A systematic review
and meta-analysis. Virchows Arch. 466:363–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HJ, Song IC, Yun HJ, Jo DY and Kim S:
CXC chemokines and chemokine receptors in gastric cancer: From
basic findings towards therapeutic targeting. World J
Gastroenterol. 20:1681–1693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh JK, Farnie G, Bundred NJ, Simões BM,
Shergill A, Landberg G, Howell SJ and Clarke RB: Targeting CXCR1/2
significantly reduces breast cancer stem cell activity and
increases the efficacy of inhibiting HER2 via HER2-dependent and
-independent mechanisms. Clin Cancer Res. 19:643–656. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kakinuma T and Hwang ST: Chemokines,
chemokine receptors, and cancer metastasis. J Leukoc Biol.
79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Zhang X, Thomas SM, Grandis JR,
Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates
phosphoinositide-3 kinase-mediated invasive and prosurvival
pathways in head and neck cancer cells independent of EGFR.
Oncogene. 24:5897–5904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mburu YK, Egloff AM, Walker WH, Wang L,
Seethala RR, van Waes C and Ferris RL: Chemokine Receptor 7 (CCR7)
gene expression is regulated by NF-B and Activator Protein 1 (AP1)
in metastatic squamous cell carcinoma of head and neck (SCCHN). J
Biol Chem. 287:3581–3590. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signaling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaoka K, Maeshima K, Kubo S and Tanaka
Y: Regulation of inflammation through JAK3-Stat6 pathway in
dendritic cells. Nihon Rinsho Meneki Gakkai Kaishi. 35:62–68.
2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhavsar SK, Gu S, Bobbala D and Lang F:
Janus kinase 3 is expressed in erythrocytes, phosphorylated upon
energy depletion and involved in the regulation of suicidal
erythrocyte death. Cell Physiol Biochem. 27:547–556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Säemann MD, Zeyda M, Stulnig TM, Böhmig
GA, Wekerle T, Hörl WH and Zlabinger GJ: Janus kinase-3 (JAK3)
inhibition: A novel immunosuppressive option for allogeneic
transplantation. Transpl Int. 17:481–489. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Uckun FM, Vassilev A, Dibirdik I and
Tibbles H: Targeting JAK3 tyrosine kinase-linked signal
transduction pathways with rationally-designed inhibitors.
Anticancer Agents Med Chem. 7:612–623. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Valle-Mendiola A, Weiss-Steider B,
Rocha-Zavaleta L and Soto-Cruz I: IL-2 enhances cervical cancer
cells proliferation and JAK3/STAT5 phosphorylation at low doses,
while at high doses IL-2 has opposite effects. Cancer Invest.
32:115–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Treliński J and Robak T: JAK inhibitors:
Pharmacology and clinical activity in chronic myeloprolipherative
neoplasms. Curr Med Chem. 20:1147–1161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghoreschi K, Laurence A and O'Shea JJ:
Janus kinases in immune cell signaling. Immunol Rev. 228:273–287.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang HL, Chiang CH, Hung WC and Hou MF:
Targeting of TGF-β-activated protein kinase 1 inhibits chemokine
(C-C motif) receptor 7 expression, tumor growth and metastasis in
breast cancer. Oncotarget. 6:995–1007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
van den Bosch T, Koopmans AE, Vaarwater J,
van den Berg M, de Klein A and Verdijk RM: Chemokine receptor CCR7
expression predicts poor outcome in uveal melanoma and relates to
liver metastasis whereas expression of CXCR4 is not of clinical
relevance. Invest Ophthalmol Vis Sci. 54:7354–7361. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arigami T, Natsugoe S, Uenosono Y,
Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and
CXCR4 expression predicts lymph node status including
micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through JAK2/STAT3 in metastatic squamous cell carcinoma of the
head and neck. Biomed Res Int. 2014:4153752014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu FY, Zhao ZJ, Li P, Ding X, Guo N, Yang
LL, Zong ZH and Sun CF: NF-κB participates in chemokine receptor
7-mediated cell survival in metastatic squamous cell carcinoma of
the head and neck. Oncol Rep. 25:383–391. 2011.PubMed/NCBI
|
|
36
|
Martin SK, Kamelgarn M and Kyprianou N:
Cytoskeleton targeting value in prostate cancer treatment. Am J
Clin Exp Urol. 2:15–26. 2014.PubMed/NCBI
|
|
37
|
Mashino K, Sadanaga N, Yamaguchi H, Tanaka
F, Ohta M, Shibuta K, Inoue H and Mori M: Expression of chemokine
receptor CCR7 is associated with lymph node metastasis of gastric
carcinoma. Cancer Res. 62:2937–2941. 2002.PubMed/NCBI
|
|
38
|
Baggiolini M: Chemokines and leukocyte
traffic. Nature. 392:565–568. 1998. View
Article : Google Scholar : PubMed/NCBI
|
